FDA Suggests It Favors Controls on Accutane
GAITHERSBURG, MD - The Food and Drug Administration (FDA) has suggested that they are in favor of strong controls on the acne drug Accutane, which can cause severe birth defects when taken by pregnant women. Babies born to women using Accutane while pregnant have a 20% to 25% chance of having severe abnormalities in their brains, hearts, and other organs. During the first of two meetings, the FDA presented plans to prevent pregnant women from using the drug.
The first initiative calls for doctors and patients to register in order to gain access to the drug. Physicians would perform pregnancy tests before prescribing it, and the patient would have to report any contraceptives she was using. A pharmacist would also have to confirm that there was a negative pregnancy test before dispensing the prescription. The second scenario would add to these restrictions a requirement that pharmacies supplying the drug be specially trained, registered, and authorized.
The FDA approved Accutane in 1982. Since then, 1,995 pregnancies have been reported by women on the medication. 70% of these pregnancies occurred after the drug's manufacturer, Hoffmann-La Roche Inc., Nutley, NJ, put in place an extensive pregnancy-prevention program, that included repeated warnings and recommendations for pregnancy test prior to prescribing the drug. For more information visit www.wsj.com.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
